Skip to main content

Triptorelin (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Triptorelin (triptorelin systemic) is a member of the following drug classes: gonadotropin releasing hormones, hormones/antineoplastics and is used to treat Precocious Puberty and Prostate Cancer.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02AE04

CAS registry number (Chemical Abstracts Service)

0057773-63-4

Chemical Formula

C64-H82-N18-O13

Molecular Weight

1312

Therapeutic Categories

Antineoplastic agent

Gonadotropin releasing hormone (GnRH) agonist

Chemical Name

Luteinizing hormone-releasing factor (pig), 6-D-tryptophan-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs